<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid/><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid">PMC4927852</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid-ver">PMC4927852.1</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaid">4927852</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaiid">4927852</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">26444762</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.3233/JAD-150253</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">JAD150253</article-id></all-ids><extracted-table><table-id>jad-48-4-jad150253-t001</table-id><table-label>Table 1</table-label><table-caption>Demographic, clinical and biomarker data of the population</table-caption><table-wrap-foot>Data are presented as mean (± standard deviation), except for the age range (years), HCA scores (n), and APOEɛ4 carriers (%). MMSE scores were only considered when the time lap between MMSE and the MRI scan was equal to or less than three months. An independent sample t-test was performed to compare the age, MMSE scores and CSF biomarker levels of the groups. Mann-Whitney U-tests were used to compare HCA and % APOEɛ4 carriers between the groups. AD, Alzheimer’s disease; MCI, mild cognitive impairment; CO, control; n, number; MoCA, Montreal Cognitive Assessment; APOE, apolipoprotein E; CSF, cerebrospinal fluid; HCA, hippocampal atrophy.  ***p &lt;  0.001.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="jad-48-4-jad150253-t001" orientation="portrait" position="float"><label>Table 1</label><caption><p>Demographic, clinical and biomarker data of the population</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead valign="top"><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">MCI</td><td rowspan="1" colspan="1">AD</td><td rowspan="1" colspan="1">CO</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">N</td><td rowspan="1" colspan="1">18</td><td rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1">14</td></tr><tr><td rowspan="1" colspan="1">F / M</td><td rowspan="1" colspan="1">8 / 10</td><td rowspan="1" colspan="1">13 / 6</td><td rowspan="1" colspan="1">6 / 8</td></tr><tr><td rowspan="1" colspan="1">Age</td><td rowspan="1" colspan="1">74.9 (±8.7)</td><td rowspan="1" colspan="1">72.8 (±8.9)</td><td rowspan="1" colspan="1">69.7 (±7.5)</td></tr><tr><td rowspan="1" colspan="1">Age range</td><td rowspan="1" colspan="1">49 –88</td><td rowspan="1" colspan="1">50 –88</td><td rowspan="1" colspan="1">59 –83</td></tr><tr><td rowspan="1" colspan="1">MMSE (/30)</td><td rowspan="1" colspan="1">28 (±1)<sup> ***</sup><italic toggle="yes">n</italic> = 10</td><td rowspan="1" colspan="1">21 (±4)<sup> ***</sup><italic toggle="yes">n</italic> = 13</td><td rowspan="1" colspan="1">/</td></tr><tr><td rowspan="1" colspan="1">MoCA (/30)</td><td rowspan="1" colspan="1">/</td><td rowspan="1" colspan="1">/</td><td rowspan="1" colspan="1">27 (±1)</td></tr><tr><td rowspan="1" colspan="1">% <italic toggle="yes">APOE</italic><italic toggle="yes">ɛ</italic>4 carriers</td><td rowspan="1" colspan="1">60 <italic toggle="yes">n</italic> = 10</td><td rowspan="1" colspan="1">69 <italic toggle="yes">n</italic> = 13</td><td rowspan="1" colspan="1">/</td></tr><tr><td rowspan="1" colspan="1">CSF A<italic toggle="yes">β</italic><sub>1 - 42</sub> (pg/mL)</td><td rowspan="1" colspan="1">560 (±152) <italic toggle="yes">n</italic> = 15</td><td rowspan="1" colspan="1">600 (±143) <italic toggle="yes">n</italic> = 11</td><td rowspan="1" colspan="1">/</td></tr><tr><td rowspan="1" colspan="1">CSF T-tau (pg/mL)</td><td rowspan="1" colspan="1">463 (±256) <italic toggle="yes">n</italic> = 15</td><td rowspan="1" colspan="1">605 (±284) <italic toggle="yes">n</italic> = 11</td><td rowspan="1" colspan="1">/</td></tr><tr><td rowspan="1" colspan="1">CSF P-tau<sub>181P</sub> (pg/mL)</td><td rowspan="1" colspan="1">61.6 (±28.0) <italic toggle="yes">n</italic> = 15</td><td rowspan="1" colspan="1">88.7 (±42.0) <italic toggle="yes">n</italic> = 11</td><td rowspan="1" colspan="1">/</td></tr><tr><td rowspan="1" colspan="1">HCA (n)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">6</td></tr><tr><td rowspan="1" colspan="1">HCA 1 (n)</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">5</td></tr><tr><td rowspan="1" colspan="1">HCA 2 (n)</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">2</td></tr><tr><td rowspan="1" colspan="1">HCA 3 (n)</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">1</td></tr><tr><td rowspan="1" colspan="1">HCA 4 (n)</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">0</td></tr></tbody></table><table-wrap-foot><p>Data are presented as mean (± standard deviation), except for the age range (years), HCA scores (n), and <italic toggle="yes">APOE</italic><italic toggle="yes">ɛ</italic>4 carriers (%). MMSE scores were only considered when the time lap between MMSE and the MRI scan was equal to or less than three months. An independent sample <italic toggle="yes">t</italic>-test was performed to compare the age, MMSE scores and CSF biomarker levels of the groups. Mann-Whitney U-tests were used to compare HCA and % <italic toggle="yes">APOE</italic><italic toggle="yes">ɛ</italic>4 carriers between the groups. AD, Alzheimer’s disease; MCI, mild cognitive impairment; CO, control; n, number; MoCA, Montreal Cognitive Assessment; <italic toggle="yes">APOE</italic>, apolipoprotein E; CSF, cerebrospinal fluid; HCA, hippocampal atrophy. <sup> ***</sup><italic toggle="yes">p</italic> &lt;  0.001.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic, clinical and biomarker data of the population</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><td/><td>MCI</td><td>AD</td><td>CO</td></tr></thead><tbody><tr><td>N</td><td>18</td><td>19</td><td>14</td></tr><tr><td>F / M</td><td>8 / 10</td><td>13 / 6</td><td>6 / 8</td></tr><tr><td>Age</td><td>74.9 (±8.7)</td><td>72.8 (±8.9)</td><td>69.7 (±7.5)</td></tr><tr><td>Age range</td><td>49 –88</td><td>50 –88</td><td>59 –83</td></tr><tr><td>MMSE (/30)</td><td>28 (±1) ***n = 10</td><td>21 (±4) ***n = 13</td><td>/</td></tr><tr><td>MoCA (/30)</td><td>/</td><td>/</td><td>27 (±1)</td></tr><tr><td>% APOEɛ4 carriers</td><td>60 n = 10</td><td>69 n = 13</td><td>/</td></tr><tr><td>CSF Aβ1 - 42 (pg/mL)</td><td>560 (±152) n = 15</td><td>600 (±143) n = 11</td><td>/</td></tr><tr><td>CSF T-tau (pg/mL)</td><td>463 (±256) n = 15</td><td>605 (±284) n = 11</td><td>/</td></tr><tr><td>CSF P-tau181P (pg/mL)</td><td>61.6 (±28.0) n = 15</td><td>88.7 (±42.0) n = 11</td><td>/</td></tr><tr><td>HCA (n)</td><td>0</td><td>1</td><td>6</td></tr><tr><td>HCA 1 (n)</td><td>7</td><td>5</td><td>5</td></tr><tr><td>HCA 2 (n)</td><td>5</td><td>4</td><td>2</td></tr><tr><td>HCA 3 (n)</td><td>4</td><td>7</td><td>1</td></tr><tr><td>HCA 4 (n)</td><td>2</td><td>2</td><td>0</td></tr></tbody></table></div>Data are presented as mean (± standard deviation), except for the age range (years), HCA scores (n), and APOEɛ4 carriers (%). MMSE scores were only considered when the time lap between MMSE and the MRI scan was equal to or less than three months. An independent sample t-test was performed to compare the age, MMSE scores and CSF biomarker levels of the groups. Mann-Whitney U-tests were used to compare HCA and % APOEɛ4 carriers between the groups. AD, Alzheimer’s disease; MCI, mild cognitive impairment; CO, control; n, number; MoCA, Montreal Cognitive Assessment; APOE, apolipoprotein E; CSF, cerebrospinal fluid; HCA, hippocampal atrophy.  ***p &lt;  0.001.</transformed-table></extracted-table><extracted-table><table-id>jad-48-4-jad150253-t002</table-id><table-label>Table 2</table-label><table-caption>Brain regions with one or more clusters reaching statistical significance (p &lt;  0.05) after FWE correction on cluster level for multiple comparison in AD versus CO</table-caption><table-wrap-foot>FA, fractional anisotropy; MD, mean diffusivity; MK, mean kurtosis.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="jad-48-4-jad150253-t002" orientation="portrait" position="float"><label>Table 2</label><caption><p>Brain regions with one or more clusters reaching statistical significance (<italic toggle="yes">p</italic> &lt;  0.05) after FWE correction on cluster level for multiple comparison in AD versus CO</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/></colgroup><thead valign="top"><tr><td rowspan="1" colspan="1">Brain region</td><td rowspan="1" colspan="1">Cluster level FWE corrected <italic toggle="yes">p</italic> value</td></tr></thead><tbody><tr><td rowspan="1" colspan="1"><italic toggle="yes">FA</italic></td></tr><tr><td rowspan="1" colspan="1">Cerebellar peduncles</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Cerebellar peduncles</td><td rowspan="1" colspan="1">0.009</td></tr><tr><td rowspan="1" colspan="1">Inferior longitudinal fasciculus</td><td rowspan="1" colspan="1">0.016</td></tr><tr><td rowspan="1" colspan="1">Cingulum</td><td rowspan="1" colspan="1">0.021</td></tr><tr><td rowspan="1" colspan="1">Splenium corpus callosum</td><td rowspan="1" colspan="1">0.012</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">MD</italic></td></tr><tr><td rowspan="1" colspan="1">Splenium corpus callosum</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Inferior longitudinal fasciculus</td><td rowspan="1" colspan="1">0.044</td></tr><tr><td rowspan="1" colspan="1"><italic toggle="yes">MK</italic></td></tr><tr><td rowspan="1" colspan="1">Splenium corpus callosum</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Cerebellar peduncles</td><td rowspan="1" colspan="1">&lt;0.001</td></tr></tbody></table><table-wrap-foot><p>FA, fractional anisotropy; MD, mean diffusivity; MK, mean kurtosis.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Brain regions with one or more clusters reaching statistical significance (p &lt;  0.05) after FWE correction on cluster level for multiple comparison in AD versus CO</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><colgroup><col align="left"/><col align="center"/></colgroup><thead valign="top"><tr><td>Brain region</td><td>Cluster level FWE corrected p value</td></tr></thead><tbody><tr><td>FA</td></tr><tr><td>Cerebellar peduncles</td><td>&lt;0.001</td></tr><tr><td>Cerebellar peduncles</td><td>0.009</td></tr><tr><td>Inferior longitudinal fasciculus</td><td>0.016</td></tr><tr><td>Cingulum</td><td>0.021</td></tr><tr><td>Splenium corpus callosum</td><td>0.012</td></tr><tr><td>MD</td></tr><tr><td>Splenium corpus callosum</td><td>&lt;0.001</td></tr><tr><td>Inferior longitudinal fasciculus</td><td>0.044</td></tr><tr><td>MK</td></tr><tr><td>Splenium corpus callosum</td><td>&lt;0.001</td></tr><tr><td>Cerebellar peduncles</td><td>&lt;0.001</td></tr></tbody></table></div>FA, fractional anisotropy; MD, mean diffusivity; MK, mean kurtosis.</transformed-table></extracted-table></extracted-tables-set>